- Home
- FTHM vs RADX Comparison
FTHM vs RADX Comparison
Compare FTHM & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- RADX
- Stock Information
- Founded
- FTHM 2010
- RADX 2021
- Country
- FTHM United States
- RADX Australia
- Employees
- FTHM N/A
- RADX N/A
- Industry
- FTHM Real Estate
- RADX
- Sector
- FTHM Finance
- RADX
- Exchange
- FTHM Nasdaq
- RADX NYSE
- Market Cap
- FTHM 33.6M
- RADX 32.5M
- IPO Year
- FTHM 2020
- RADX N/A
- Fundamental
- Price
- FTHM $1.26
- RADX $4.20
- Analyst Decision
- FTHM Buy
- RADX Strong Buy
- Analyst Count
- FTHM 1
- RADX 2
- Target Price
- FTHM $2.50
- RADX $13.50
- AVG Volume (30 Days)
- FTHM 88.3K
- RADX 17.8K
- Earning Date
- FTHM 08-11-2025
- RADX 02-26-2025
- Dividend Yield
- FTHM N/A
- RADX N/A
- EPS Growth
- FTHM N/A
- RADX N/A
- EPS
- FTHM N/A
- RADX N/A
- Revenue
- FTHM $357,816,000.00
- RADX $204,609.00
- Revenue This Year
- FTHM $32.40
- RADX N/A
- Revenue Next Year
- FTHM $18.04
- RADX N/A
- P/E Ratio
- FTHM N/A
- RADX N/A
- Revenue Growth
- FTHM 5.80
- RADX N/A
- 52 Week Low
- FTHM $0.65
- RADX $3.50
- 52 Week High
- FTHM $3.37
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- FTHM 51.56
- RADX N/A
- Support Level
- FTHM $1.27
- RADX N/A
- Resistance Level
- FTHM $1.36
- RADX N/A
- Average True Range (ATR)
- FTHM 0.11
- RADX 0.00
- MACD
- FTHM -0.01
- RADX 0.00
- Stochastic Oscillator
- FTHM 53.12
- RADX 0.00
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.